Use of intrathecal baclofen for treatment of severe spasticity in selected patients with motor neuron disease

Neurorehabilitation and Neural Repair

Volumn 27, Issue 9, 2013, Pages 828-833

  Bethoux, Francois ^a   Boulis, Nicholas ^a,b   McClelland, Shearwood ^a,c   Willis, Mary Alissa ^a   Hussain, Mariam ^a   Machado, Andre ^a   Mychkovsky, Lydia ^a   Stough, Darlene ^a   Sutliff, Matt ^a   Pioro, Erik P ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b EMORY UNIVERSITY   (United States)

^c BOSTON UNIVERSITY   (United States)

Author keywords

intrathecal baclofen; motor neuron disease; spasticity

Indexed keywords

BACLOFEN; TIZANIDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONSERVATIVE TREATMENT; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; MALE; MOTOR NEURON DISEASE; PAIN ASSESSMENT; POSTOPERATIVE CARE; SPASTICITY;

INTRATHECAL BACLOFEN; MOTOR NEURON DISEASE; SPASTICITY;

BACLOFEN; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, SPINAL; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; MUSCLE SPASTICITY; PAIN MEASUREMENT;

EID: 84885403471     PISSN: 15459683     EISSN: 15526844     Source Type: Journal    
DOI: 10.1177/1545968313496325     Document Type: Article

References (18)

1. Rawlins PK. Intrathecal baclofen therapy over 10 years. J Neurosci Nurs. 2004 ; 36: 322-327
2. Francisco GE. The role of intrathecal baclofen therapy in the upper motor neuron syndrome. Eur Med Phys. 2004 ; 40: 131-143
3. Sadiq SA, Wand GC. Long-term intrathecal baclofen therapy in ambulatory patients with spasticity. J Neurol. 2006 ; 253: 563-569
4. Kuipers-Upmeijer J, de Jager AEJ, Hew JM, et al. Primary lateral sclerosis: clinical, neurophysiological, and magnetic resonance findings. J Neurol Neurosurg Psychiatry. 2001 ; 71: 615-620
5. Sabetelli M, Zollino M, Luigetti M, et al. Uncovering amyotrophic lateral sclerosis phenotypes: clinical features and long-term follow-up of upper motor neuron-dominant ALS. Amyotroph Lateral Scler. 2011 ; 12: 278-282
6. Marquardt G, Seifert V. Use of intrathecal baclofen for treatment of spasticity in amytrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2002 ; 72: 275-276
7. Milano J, Neto M, Hunhevicz S, et al. Intrathecal baclofen for spasticity in primary lateral sclerosis. J Neurol. 2005 ; 252: 740-741
8. McClelland S, Bethoux FA, Boulis NM, et al. Intrathecal baclofen for spasticity-related pain in amytrophic lateral sclerosis: efficacy and factors associated with pain relief. Muscle Nerve. 2008 ; 37: 396-398
9. Williamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs. 2005 ; 14: 798-804
10. Cuthbert SC, Goodheart GJ. On the reliability and validity of manual muscle testing: a literature review. Chiropr Osteopat. 2007 ; 15: 4
11. Bohannon R, Smith M. Inter-rate reliability of a modified Ashworth scale of muscle spasticity. Phys Ther. 1987 ; 67: 206-207
12. Penn RD, Savoy SM, Corocs D, et al. Intrathecal baclofen for severe spinal spasticity. N Engl J Med. 1989 ; 320: 1517-1521
13. Fischer J, Rudick R, Cutter G, Reingold S. The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment. Mult Scler. 1999 ; 5: 244-250
14. Albright AL, Turner M, Pattisapu JV. Best-practice surgical techniques for intrathecal baclofen therapy. J Neurosurg. 2006 ; 104: 233-239
15. Soraru G, Ermani M, Logroscino G, et al. Natural history of upper motor neuron-dominant ALS. Amyotroph Lateral Scler. 2010 ; 11: 424-429
16. Blackhall LJ. Amyotrophic lateral sclerosis and palliative care: where we are, and the road ahead. Muscle Nerve. 2012 ; 45: 311-318
17. Bleyenheuft C, Filipetti P, Caldas C, Lejeune T. Experience with external pump trial prior to implantation for intrathecal baclofen in ambulatory patients with spastic cerebral palsy. Neurophysiol Clin. 2007 ; 37: 23-28
18. Harned ME, Salles SS, Grider JS. An introduction to trialing intrathecal baclofen in patients with hemiparetic spasticity: a description of 3 cases. Pain Phys. 2011 ; 14: 483-489